STAT3 and neoplasm: Similarly, tumor-derived kynurenine hyperactivates Tregs, leading to increased IL-10 secretion which promotes chemotherapy resistance in gastric cancer via the STAT3/BCL2 signaling pathway (Fig. 6A).